Home > PB Ratio > LYKA LABS

LYKA LABS
PB (Price/Book ) Ratio

The Current P/B Ratio of LYKA LABS is 14.59.

Share Price ₹123.4Apr 26,2024
Market Cap ₹408.5 Cr
Book Value₹28.0 CrMar2023 - Consolidated Results
Price/Book 14.59xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for LYKA LABS
Please provide your vote to see the results
LYKA LABS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PB (Price/Book ) ratio of LYKA LABS

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of LYKA LABS is calculated as :

Current Market Cap [ ₹408.5 Cr] as on Apr 26,2024

(/) Book Value [ ₹28.0 Cr] based on Mar2023 - Consolidated Results

(=) P/B Ratio [ 14.59x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for LYKA LABS , the investors are currently willing to pay '14.59 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of LYKA LABS !

The chart below summarizes the trend in P/B Ratio of LYKA LABS over the last five years.

Historical PB (Price/Book ) ratio chart of LYKA LABS


PB Ratio Performance Analysis for LYKA LABS

- LYKA LABS 's latest p/b ratio is 14.59x.

- LYKA LABS 's p/b ratio for fiscal years ending Mar2023 to Mar2019 averaged 7.37x.

- LYKA LABS 's operated at median p/b ratio of 1.63x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, LYKA LABS 's p/b ratio peaked in Mar2022 at 29.17x.

- LYKA LABS 's p/b ratio hit its five-year low in Mar2021 of -2.89x.


How does LYKA LABS 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
LYKA LABS 28.0014.59408.5
SUN PHARMACEUTICAL INDUSTRIES LTD55,995.406.45360,920.0
CIPLA LTD23,346.004.87113,794.0
DR REDDYS LABORATORIES LTD23,140.404.51104,316.0
ZYDUS LIFESCIENCES LTD17,515.805.4595,380.9
DIVIS LABORATORIES LTD12,767.108.37106,860.0
MANKIND PHARMA LTD7,435.1612.7694,869.4
TORRENT PHARMACEUTICALS LTD6,198.0714.6991,057.0
LUPIN LTD12,315.605.9873,642.4
AUROBINDO PHARMA LTD26,839.802.4766,278.5
ABBOTT INDIA LTD3,146.0217.4754,961.0

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs LYKA LABS 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 2.47x
Max industry PB 17.47x
Median industry PB 6.45x
Average industry PB 8.87x



You may also like the below Video Courses